| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.42B | 2.32B | 2.31B | 2.32B | 2.09B |
| Gross Profit | 1.52B | 1.43B | 1.40B | 1.41B | 1.29B |
| EBITDA | 526.10M | 503.00M | 485.30M | 544.70M | 515.10M |
| Net Income | 267.70M | 249.30M | 254.60M | 374.20M | 314.50M |
Balance Sheet | |||||
| Total Assets | 2.35B | 2.24B | 2.06B | 2.03B | 2.05B |
| Cash, Cash Equivalents and Short-Term Investments | 344.50M | 343.60M | 282.80M | 308.00M | 515.30M |
| Total Debt | 1.31B | 681.00M | 684.50M | 665.30M | 591.20M |
| Total Liabilities | 1.16B | 1.11B | 1.09B | 1.16B | 1.06B |
| Stockholders Equity | 1.19B | 1.13B | 978.40M | 871.70M | 991.50M |
Cash Flow | |||||
| Free Cash Flow | 342.30M | 278.10M | 253.40M | 255.60M | 351.50M |
| Operating Cash Flow | 498.80M | 400.10M | 372.30M | 396.40M | 437.40M |
| Investing Cash Flow | -156.40M | -112.10M | -114.20M | -154.70M | -85.80M |
| Financing Cash Flow | -340.70M | -228.90M | -285.40M | -444.60M | -267.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £56.56M | 3.42 | 20.89% | 0.55% | 2.64% | 23.89% | |
72 Outperform | £4.47B | 16.92 | 23.58% | 2.57% | 0.13% | -0.06% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £300.41M | 4.43 | 13.23% | ― | 4.38% | ― | |
49 Neutral | £40.47M | 9.31 | -22.13% | 3.45% | -4.23% | -435.86% | |
45 Neutral | £43.83M | -0.14 | 67.51% | ― | -9.72% | 10.94% | |
42 Neutral | £24.80M | -0.46 | -61.90% | ― | -11.65% | -273.57% |